| Incyte Biosciences International Sàrl - Pemazyre 13,5 mg, comprimés | | 68143 | | 03 | | Pemazyre 13,5 mg | | comprimés | | L01EN02 | | | | 13.07.2021 | | |
| | Composition | | pemigatinibum 13.5 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.528 mg, magnesii stearas, pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Pemigatinibum | 13.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Pemigatinibum | 13.5 mg |
| | | | Inactive agents |
|---|
| Carboxymethylamylum Natricum A | | Cellulosum Microcristallinum | | Magnesii Stearas | | Pro Compresso |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
